{"id":"https://genegraph.clinicalgenome.org/r/b062446a-6e22-4d1a-8428-6d2188ff7dbav3.0","type":"EvidenceStrengthAssertion","dc:description":"CSRP3 was originally evaluated for DCM by the ClinGen DCM GCEP on 11/06/2020. Evidence of the association of this gene with DCM was re-evaluated using SOP v10 on 05/30/2025. As a result, the classification changed from limited to no known disease relationship. A summary of the information contributing to the classification of this gene at the time of re-evaluation is summarized herein. \n\nCSRP3 was first reported in relation to autosomal dominant dilated cardiomyopathy (DCM) in 2002 (Knoll et al. 2002, PMID: 12507422). Human genetic evidence supporting this gene-disease relationship includes case-level and case-control data. At least four missense variants have been reported in humans with DCM (Mohapatra et al. 2003, PMID 14567970; Hershberger et al. 2008, PMID 19412328; Shakeel M et al. 2018, PMID 29776034; and Zimmerman et al. 2010, PMID 20474083). Two case-control studies did not find evidence of enrichment of the missense variant in cases, however, the confidence intervals were wide due to limited sample size (Mazzarotto et al. 2020, PMID 31983221; Walsh et al. 2017, PMID 27532257). \nIn 2022, Trachoo et al. PMID 36166435 identified a missense variant in a cohort of DCM patients from Thailand. \nThis gene-disease assertion is supported by experimental data from expression studies and animal, ex-vivo, and cell culture models. Arber et al. (1997, PMID 9039266) reported the phenotype of a transgenic homozygous CSRP3-null mouse, demonstrating defects of the cardiomyocyte cytoskeletal architecture with Z-disc misalignment and myofibrillar disarray. Knoll et al. (2002, PMID 12507422) demonstrated a defect in cardiomyocyte stretch-induced response. No further scorable variants were identified in the re-curation process. No convincing evidence for a causal role for CSRP3 and AD DCM has been reported. Although this gene-disease assertion is supported by experimental evidence, there is limited convincing genetic evidence that have directly implicated this gene in human disease. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on 05/30/2025 (SOP Version 10). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b062446a-6e22-4d1a-8428-6d2188ff7dba","GCISnapshot":"https://genegraph.clinicalgenome.org/r/beaafc90-20ef-4c81-ad8f-cfcf69d269ca","calculatedEvidenceStrength":"Limited","changes":{"id":"cg:classificationChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/beaafc90-20ef-4c81-ad8f-cfcf69d269ca_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2025-10-15T12:55:28.596Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/beaafc90-20ef-4c81-ad8f-cfcf69d269ca_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2025-05-30T16:00:00.000Z","role":"Approver"}],"curationReasonDescription":"DCM GCEP agreed to downgrade this gene to no known disease relationship due to very limited new genetic evidence available since the initial curation. ","curationReasons":["RecurationTiming"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/beaafc90-20ef-4c81-ad8f-cfcf69d269ca_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/494b3e6b-9c52-496e-bd13-a3193e29d57b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/494b3e6b-9c52-496e-bd13-a3193e29d57b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20474083","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a5b915e-cc9c-4288-9d56-4039a7c6d9c2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003476.5(CSRP3):c.535A>G (p.Thr179Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA134910"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/69e5ddcd-e3a0-44ba-ad02-061a3316719e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/69e5ddcd-e3a0-44ba-ad02-061a3316719e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36166435","allele":{"id":"https://genegraph.clinicalgenome.org/r/da9591cd-365e-4593-88ee-bf5823b14672","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003476.5(CSRP3):c.571G>A (p.Glu191Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379887466"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3deef88b-5941-408c-ba8c-ee1beb5c6f0f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3deef88b-5941-408c-ba8c-ee1beb5c6f0f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20474083","allele":{"id":"https://genegraph.clinicalgenome.org/r/874a7f4b-3678-4952-9555-f080f115a25c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003476.5(CSRP3):c.148G>A (p.Ala50Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA134872"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/495790b2-d0ed-44b6-8e07-1ca2b59802b0","type":"EvidenceLine","dc:description":"Possible phenocopy or non-DCM phenotype.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/495790b2-d0ed-44b6-8e07-1ca2b59802b0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14567970","allele":{"id":"https://genegraph.clinicalgenome.org/r/15d50ba2-b63d-413e-985d-68532a5afdb8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003476.5(CSRP3):c.206A>G (p.Lys69Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254551"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/8a13bd00-2086-4089-8b0a-62128e6632a8","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a13bd00-2086-4089-8b0a-62128e6632a8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19412328","allele":{"id":"https://genegraph.clinicalgenome.org/r/346b9f47-548d-4caa-a51f-78c114986ae2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003476.5(CSRP3):c.214G>A (p.Gly72Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5916623"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/57e2e5d1-257a-4e74-85eb-5be5b3c0b5da","type":"EvidenceLine","dc:description":"The parents of all patients were cousins or blood relatives. This case (Table 2) had 98 predicted deleterious missense SNVs (heterozygous) and 8 predicted deleterious missense (SNVs) which were not further detailed as well as one TTN missense variant. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57e2e5d1-257a-4e74-85eb-5be5b3c0b5da_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29886034","allele":{"id":"https://genegraph.clinicalgenome.org/r/3342b38e-98ee-469f-8602-65abcc00fe7e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003476.5(CSRP3):c.2T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379888706"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/beaafc90-20ef-4c81-ad8f-cfcf69d269ca_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cdb55b3d-6c41-417d-bfb0-ff385c1c87c3_proband_segregation","type":"FamilyCosegregation","dc:description":"Too few segregations.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14567970","rdfs:label":"EFE-P","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/cdb55b3d-6c41-417d-bfb0-ff385c1c87c3","type":"Family","rdfs:label":"EFE-P","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c9a27568-9c9c-49bc-b7cf-77c751570094","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14567970","rdfs:label":"ML","allele":{"id":"https://genegraph.clinicalgenome.org/r/15d50ba2-b63d-413e-985d-68532a5afdb8"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/495790b2-d0ed-44b6-8e07-1ca2b59802b0_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/c9a27568-9c9c-49bc-b7cf-77c751570094"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/beaafc90-20ef-4c81-ad8f-cfcf69d269ca_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e48ebfd-5ee9-4ef4-9a6a-ab99912b6214","type":"EvidenceLine","dc:description":"This is a high-quality study that does not support rare CSRP3 variants as a cause of penetrant Mendelian dilated cardiomyopathy.","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e48ebfd-5ee9-4ef4-9a6a-ab99912b6214_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","rdfs:label":"Primary cohort","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/02c45937-1afb-4853-94cc-b793737d725e","type":"Cohort","allGenotypedSequenced":1040,"alleleFrequency":0.002884615384615385,"detectionMethod":"\"Fifty-six genes with ≥1 variant reported as pathogenic for DCM between 1996 and 2015 in the Human Gene Mutation Database (professional v2015.3) and included on the Illumina TruSight Cardio panel were selected for inclusion in the analysis\"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e48ebfd-5ee9-4ef4-9a6a-ab99912b6214_cc_evidence_item"}],"numWithVariant":3,"relatedCondition":{"id":"obo:MONDO_0005021"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/b37b6806-f092-47af-a538-c50f18df9805","type":"Cohort","allGenotypedSequenced":912,"alleleFrequency":0.002192982456140351,"detectionMethod":"\"Fifty-six genes with ≥1 variant reported as pathogenic for DCM between 1996 and 2015 in the Human Gene Mutation Database (professional v2015.3) and included on the Illumina TruSight Cardio panel were selected for inclusion in the analysis\"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e48ebfd-5ee9-4ef4-9a6a-ab99912b6214_cc_evidence_item"}],"numWithVariant":2},"method":{"id":"cg:AggregateVariantAnalysis"},"pValue":0.56136198,"statisticalSignificanceType":"","statisticalSignificanceValue":1,"statisticalSignificanceValueType":"Odds Ratio"}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3c06135c-6373-4e08-8ee2-287ca1870f8b","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c06135c-6373-4e08-8ee2-287ca1870f8b_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27532257","rdfs:label":"Walsh2017_LMM_OMGL","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/e6b3de5a-8619-48ba-99c6-4fc51dab6c65","type":"Cohort","allGenotypedSequenced":941,"alleleFrequency":0.004250797024442083,"detectionMethod":"High-resolution DNA melting (WAVE dHPLC, LightScanner®)\nSanger sequencing\nTargeted NGS","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c06135c-6373-4e08-8ee2-287ca1870f8b_cc_evidence_item"}],"numWithVariant":4,"relatedCondition":{"id":"obo:MONDO_0005021"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/721f7d2e-5039-48d4-9204-8dfefc27659d","type":"Cohort","allGenotypedSequenced":60450,"alleleFrequency":0.00325889164598842,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c06135c-6373-4e08-8ee2-287ca1870f8b_cc_evidence_item"}],"numWithVariant":197},"lowerConfidenceLimit":0.48,"method":{"id":"cg:AggregateVariantAnalysis"},"statisticalSignificanceType":"","statisticalSignificanceValue":1.3,"statisticalSignificanceValueType":"Odds Ratio","upperConfidenceLimit":3.52}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0.4},{"id":"https://genegraph.clinicalgenome.org/r/beaafc90-20ef-4c81-ad8f-cfcf69d269ca_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/beaafc90-20ef-4c81-ad8f-cfcf69d269ca_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96240ddd-36fb-44d1-9bcc-9323c4b5c905","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ff86581-9b76-4a6e-a61c-3c62d1227c9c","type":"Finding","dc:description":"In situ localization of CSRP3 in the developing mouse heart. The expression of CSPR3 transcripts in the adult human heart also demonstrated in GTEx.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9039266","rdfs:label":"In situ localization of MLP in the developing mouse heart","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/39cbffdc-05d0-4115-a3aa-167f3b61846d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab27f764-052a-4211-8bd3-f7c64cb37ba7","type":"Finding","dc:description":"The overstretching of myocytes and lack of stretch-induced survival signals postulated to predispose to dilated cardiomyopathy.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12507422","rdfs:label":"Loss of Passive Stretch ","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/beaafc90-20ef-4c81-ad8f-cfcf69d269ca_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b1b7e7f4-ad44-4f52-a091-164fb2d486aa","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5e2ffd3-1966-417a-976b-dab342ad6c6a","type":"FunctionalAlteration","dc:description":"Disorganization of cardiac myocyte cytoarchitecture observed in MLP-deficient mice.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9039266","rdfs:label":"Culture of adult MLP-/- cardiomyocytes"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/66da19ac-9f22-4173-b3ae-23051186122f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e02c403-58c8-4162-9991-4cd6aba344cb","type":"FunctionalAlteration","dc:description":"Selective Loss of Passive Stretch-Induced Responses in Neonatal/Perinatal MLP Null Cardiomyocytes","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12507422","rdfs:label":"Loss of Stretch-Induced Responses in MLP null myocytes"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/beaafc90-20ef-4c81-ad8f-cfcf69d269ca_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc4915ca-578a-405a-83e0-6ffbf6666b05","type":"EvidenceLine","dc:description":"Evidence from single-cell reported with imaging demonstrating only partial rescue of myofibrillar disarray.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51a82ff9-1086-40fb-9e63-3669aababa23","type":"Finding","dc:description":"Partial rescue of myofibrillar disarray in culture neonatal cardiomyocytes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9039266","rdfs:label":"Transfection of neonatal MLP-/- cardiomyocytes with MLP","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/91ff6e33-b884-445f-a29c-39d5cc1cb1a0","type":"EvidenceLine","dc:description":"Heterozygous knock out mice had no detectable phenotype.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/950eaebc-be4d-47f2-8474-7e569e720169","type":"Finding","dc:description":"MLP-deficient mice develop ventricular hypertrophy and enlargement either in the early post-natal period or in adulthood. Histological examination demonstrates disrupted cytoskeletal architecture of cardiac myocytes with Z-disc misalignment and myofibrillar disarray.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9039266","rdfs:label":"MLP -/- transgenic mouse phenotype","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"NoKnownDiseaseRelationship","sequence":12015,"specifiedBy":"GeneValidityCriteria10","strengthScore":3.9,"subject":{"id":"https://genegraph.clinicalgenome.org/r/LRpiqLW17ow","type":"GeneValidityProposition","disease":"obo:MONDO_0005021","gene":"hgnc:2472","modeOfInheritance":"obo:HP_0000006"},"version":"3.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_beaafc90-20ef-4c81-ad8f-cfcf69d269ca-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}